Autoliv (ALIV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for May 8, 2025, both in-person and virtually, with voting on director elections, executive compensation, and auditor ratification.
All proxy materials, including the annual and sustainability report, are available online.
The board recommends voting for all director nominees, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Shareholders will vote on the election of 11 directors, an advisory say-on-pay vote, and ratification of Ernst & Young AB as auditor.
Only shareholders of record as of March 12, 2025, may vote.
No additional shareholder proposals or director nominations will be considered at the meeting.
Board of directors and corporate governance
10 of 11 director nominees are independent; all board committees are fully independent.
Board refreshment has resulted in five new directors in the last five years; average non-employee director tenure is eight years.
The board conducts annual self-evaluations and maintains stock ownership guidelines for directors and executives.
Board leadership is currently separated, with an independent chairman.
The board has three standing committees: Audit and Risk, Leadership Development and Compensation, and Nominating and Corporate Governance.
Latest events from Autoliv
- Profitability rose despite lower sales; 2024 guidance cut, but H2 margin and cash flow to improve.ALIV
Q2 20243 Feb 2026 - Record sales, margin expansion, and strong cash flow driven by growth in China and India.ALIV
Q4 20252 Feb 2026 - Q3 2024 outperformed global LVP, maintained margins, and reaffirmed strong 2024 guidance.ALIV
Q3 202419 Jan 2026 - Record profit and margin expansion in Q4 2024; 2025 targets higher returns amid risks.ALIV
Q4 20249 Jan 2026 - Record Q2 results, raised guidance, and major shareholder return initiatives announced.ALIV
Q2 202515 Dec 2025 - Record Q3 results with strong sales, margin gains, and strategic expansion in China.ALIV
Q3 202515 Dec 2025 - Q1 2025 saw record EPS, margin gains, and resilient sales growth amid global headwinds.ALIV
Q1 202515 Dec 2025 - Definitive additional proxy materials filed for proxy voting under SEC rules.ALIV
Proxy Filing2 Dec 2025 - All proposals passed, directors elected, and no shareholder questions or new business raised.ALIV
AGM 202525 Nov 2025